Charles Canter, M.D.  canter@wustl.edu

Profile picture
Lois B. Tuttle And Jeanne B. Hauck Professor of Pediatrics
Transplant Center Director
CardiologyCardiac Transplant Program

phone: (314) 454-6095

Education

  • BS, Brown University1974
  • MSc, Brown University1976
  • MD, Saint Louis University School of Medicine1979

Training

  • Intern, St. Louis Children's Hospital, St. Louis, MO1979 - 1980
  • Assistant Resident, St. Louis Children's Hospital1980 - 1982
  • Resident-Fellow, St. Louis Children's Hospital1982 - 1984

Licensure and Board Certification

  • IL, Medical License
  • MO, Medical License
  • 1980 - PresNational Board of Medical Examiners
  • 1984 - PresAmerican Board of Pediatrics
  • 1988 - PresAPB, Sub-Board of Pediatric Cardiology, recertified 1995,recertified 2002,recertified 2015

Honors and Awards

  • Fellowship, American Heart Association Seminar on Cardiovascular Epidemiology - Pres
  • Upjohn Achievement Award1979
  • Best Doctors in America2003
  • Medical Honoree, American Heart Association, Heartland Affiliate2004
  • New endowed professorship from St. Louis Children’s Hospital – The Lois B. Tuttle and Jeanne B. Hauck Chair in Pediatrics.2012 - Pres
  • Parkway School District Hall of Fame2016 - Pres
  • Lifetime Achievement Award, Pediatric Heart Transplant Society, November 20212021

Recent Publications view all (228)


  1. Trends in Sodium Intake in Children and Adolescents in the US and the Impact of US Department of Agriculture Guidelines J Pediatr. 2020. PMID:32600669 
  2. First year outcomes for low immunologic risk pediatric heart trasplant recipients managed with a steroid avoidance protocol: results from a multicenter prospective cohort study(CTOTC-4). I Heart Lung Transplant. 2020;972-981. 
  3. Baseline characteristics of the Valsartan for Attenuating Disease Evoltion in early Sarcomeric Hypertrophic Cardiomyopathy Cohort. Circ Heart failure. 2019. PMID:31813281 
  4. Hospital readmission following pediatric heart transplantation. Pediatr Transplant. 2019;23(7):e13561. PMID:31483086 
  5. A Recipient Risk Prediction Tool for Short-term Mortality After Pediatric Heart Transplantation. Transplantation. 2019;103(11):2434-2439. PMID:30801538 
  6. Long-term outcomes after transplantation after support with a pulsatile pediatric ventricular assist device. Journal of Heart Lung Transplant. . 2019;38(4):449-455. PMID:30466802 
  7. Early outcomes for low-risk pediatric heart transplant recipients and steroid avoidance: A multicenter cohort study (Clinical Trials in Organ Transplantation in Children - CTOTC-04). J Heart Lung Transplant. 2019. PMID:31324444 
  8. Cardiac Biomarkers in Pediatric Cardiomyopathy: Study Design and Recruitment Results from the Pediatric Cardiomyopathy Registry. Prog Pediatr Cardiol. 2019;53:1-10. PMCID:PMC6863618  PMID:31745384 
  9. Cardiac biomarkers in pediatric cardiomyopathy: study design and recruitment results from the Pediatric Cardiomyopathy Registry Prog Pediatr Cardiol . 2019;53:1-10. 
  10. Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking. Radiology. 2019;290(3):640-648. PMCID:PMC6394738  PMID:30561279 
  11. Moderate-severe primary graft dysfunction after pediatric heart transplantation. Pediatr Transplant. 2019;23(2):e13340. PMID:30609166 
  12. Center volume and outcomes in pediatric heart transplantation-Bigger is better until it isn't. Am J Transplant. 2018;18(12):2843-2844. PMID:30040193 
  13. Current Topics and Controversies in Pediatric Heart Transplantation: Proceedings of the Pediatric Heart Transplantation Summit 2017. World J Pediatr Congenit Heart Surg. 2018;9(5):575-581. PMID:30157743 
  14. Early stroke post-heart transplant is associated with decreased survival in children. J Heart Lung Transplant. 2018;37(6):733-739. PMID:29395751 
  15. Worldwide Experience of a Durable Centrifugal Flow Pump in Pediatric Patients 2018. PMID:29551744 
  16. Impact of routine surveillance biopsy intensity on the diagnosis of moderate to severe cellular rejection and survival after pediatric heart transplantation. Pediatr Transplant. 2018;22(3):e13131. PMCID:PMC5903932  PMID:29377465 
  17. Association Between Thiopurine S-Methyltransferase (TPMT) Genetic Variants and Infection in Pediatric Heart Transplant Recipients Treated With Azathioprine: A Multi-Institutional Analysis Journal of Pediatric Parmacol Therapeutics. 2018. PMID:29720911 
  18. Pediatric heart transplantation across a positive crossmatch: First year results from the CTOTC-04 multi-institutional study American Journal of Transplant. 2018. PMID:29673058 
  19. Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents with Hypertrophic Cardiomyopathy. Circulation. 2018. PMID:29622585 
  20. No Obesity Paradox in Pediatric Patients With Dilated Cardiomyopathy. JACC Heart Fail. 2018;6(3):222-230. PMCID:PMC5834393  PMID:29428438 
  21. Study rationale, design, and pretransplantation alloantibody status: A first report of Clinical Trials in Organ Transplantation in Children-04 (CTOTC-04) in pediatric heart transplantation. Am J Transplant. 2018. PMID:29446208 
  22. Incidence, characterization, and impact of newly detected donor-specific anti-HLA antibody in the first year after pediatric heart transplantation: A report from the CTOTC-04 study American Journal of Transplant. 2018. PMID:29442424 
  23. Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. J Cardiovasc Magn Reson. 2017;19(1):107. PMCID:PMC5745877  PMID:29284499 
  24. Survival Without Cardiac Transplantation Among Children With Dilated Cardiomyopathy. J Am Coll Cardiol. 2017;70(21):2663-2673. PMCID:PMC5726578  PMID:29169474 
  25. Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy. Open Heart. 2017;4(2):e000615. PMCID:PMC5687543  PMID:29177058 
  26. Berlin Heart EXCOR use in patients with congenital heart disease J Heart Lung Transplant. 2017. PMID:28259596 
  27. Design for the sacubitril/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study). American Heart Journal. 2017. PMID:29129252 
  28. End-stage renal disease after pediatric heart transplantation: A 25-year national cohort study. J Heart Lung Transplant. 2017. PMCID:PMC5880747  PMID:29055603 
  29. Outcomes and Trends of Ventricular Assist Device Selection in Children with End-Stage Heart Failure. ASAIO J. 2017;63(4):464-469. PMID:28009713 
  30. Outcomes and Trends of Ventricular Assist Device Selection in Children with End-Stage Heart Failure. ASAIO J. 2017;4(464-469):464-469. PMID:28009713  
  31. The influence of race and common genetic variations on outcomes after pediatric heart transplantation. Am J Transplant 2017 17; 1525-39. Am J Transplant 2017. 2017;1525-1539. PMID:27931092 
  32. The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study. JAMA Cardiol. 2017;2(4):419-428. PMCID:PMC5541992  PMID:28241245 
  33. Fontan Patient Survival After Pediatric Heart Transplantation Has Improved in the Current Era. Ann Thorac Surg. 2017;103(4):1315-1320. PMID:27863728 
  34. Pediatric and adult dilated cardiomyopathy represent distinct pathologic JCI Insight. 2017;14. PMID:28724792 
  35. Berlin Heart post approval outcomes in North America ASAIO J. 2017;63:193-197. PMID:28234657 
  36. Differences in presentation and outcomes between children with familial dilated cardiomyopathy and children with idiopathic dilated cardiomyopathy: A report from the Pediatric Cardiomyopathy Registry Study Group Circ Heart Failure. 2017. PMID:28193717 
  37. Differences in Presentation and Outcomes Between Children With Familial Dilated Cardiomyopathy and Children With Idiopathic Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study Group. Circ Heart Fail. 2017;10(2). PMCID:PMC5516533  PMID:28193717 
  38. The impact of age in the incidence and prevalence of moderate to severe cellular rejection detected by routine surveillance biopsy in pediatric heart transplantation J Heart Lung Transplant. 2017;36:451-456. PMID:27865735 
  39. Fitting Heart Transplantation to Adults With Congenital Heart Disease: Square Peg in a Round Hole? J Am Coll Cardiol. 2016;68(9):918-20. PMID:27561765 
  40. Systolic-diastolic functional coupling in healthy children and in those with dilated cardiomyopathy. Journal of Applied physiology. 2016. PMID:26940654 
  41. Autoimmunity Against the Heart and Cardiac Myosin in Children With Myocarditis. J Card Fail. 2016;22(7):520-8. PMID:26941007 
  42. Improved survival after heart transplant for failed Fontan patients with preserved ventricular function. J Heart Lung Transplant. 2016;35(7):877-83. PMID:27068035 
  43. Is Endomyocardial Biopsy a Safe and Useful Procedure in Children with Suspected Cardiomyopathy? Pediatr Cardiol. 2016. PMID:27272694 
  44. High Frequency of Detection by PCR of Viral Nucleic Acid in The Blood of Infants Presenting with Clinical Myocarditis. Pediatr Cardiol. 2016;37(2):399-404. PMCID:PMC4775434  PMID:26499513 
  45. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Heart Lung Transplant. 2016;35(1):1-23. PMID:26776864 
  46. Early Biventricular Assist Device Use in Children: A Single-Center Review of 31 Patients. ASAIO J. 2015;61(6):688-94. PMID:26186261 
  47. Cardiomyopathy Phenotypes and Outcomes for Children With Left Ventricular Myocardial Noncompaction: Results From the Pediatric Cardiomyopathy Registry. J Card Fail. 2015;21(11):877-84. PMCID:PMC4630116  PMID:26164213 
  48. The influence of pulmonary resistance on the success of pediatric heart transplantation: Are there still boundaries? Pediatr Transplant. 2015;19(6):580-1. PMID:26215796 
  49. Continuous Flow Device Support in Children Using the HeartWare HVAD: 1,000 Days of Lessons Learned From a Single Center Experience. ASAIO J. 2015. doi:10.1097/MAT.0000000000000253  PMID:25967955 
  50. Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy. Circulation. 2015;131(18):1590-8. PMCID:PMC4573596  PMID:25940966 
  51. Pediatric Quality of Life while Supported with a Ventricular Assist Device. Congenit Heart Dis. 2015. doi:10.1111/chd.12260  PMID:25864509 
  52. Predicting graft loss by 1 year in pediatric heart transplantation candidates: an analysis of the Pediatric Heart Transplant Study database. Circulation. 2015;131(10):890-8. doi:10.1161/CIRCULATIONAHA.114.009120  PMID:25587099 
  53. Outpatient management of intra-corporeal left ventricular assist device system in children: a multi-center experience. Am J Transplant. 2015;15(2):453-60. doi:10.1111/ajt.13003  PMID:25612114 
  54. Successful bridge through transplantation with berlin heart ventricular assist device in a child with failing fontan. Ann Thorac Surg. 2015;99(2):707-9. doi:10.1016/j.athoracsur.2014.04.064  PMID:25639417 
  55. Intravenous home inotropic use is safe in pediatric patients awaiting transplantation. Circ Heart Fail. 2015;8(1):64-70. doi:10.1161/CIRCHEARTFAILURE.114.001528  PMID:25472966 
  56. Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2014;7(6):863-71. doi:10.1161/CIRCIMAGING.114.002411  PMCID:PMC4237712  PMID:25228707 
  57. B-type natriuretic peptide trends after pediatric heart transplantation. Pediatr Transplant. 2014. PMID:24922348 
  58. Echocardiographic normalization in children with idiopathic dilated cardiomyopathy: rsults from the Pediatric Cardiomyopathy Registry. J Am Coll cardiol. 2014;63:1405. 
  59. Liver cirrhosis in fontan patients does not affect one year post-heart transplant mortality or markers of liver function J Heart Lung Transplant. 2014;33:170. 
  60. Tissue Doppler septal Tei index indicates severity of illness in pediatric patients with congestive heart failure. Pediatr cardiol. 2014;35:411. 
  61. A Multicenter study of primary graft failure after infant heart transplantation: impact extracorporeal membrane oxygenation on outcomes. Pediatr transplant. 2014;18:72. 
  62. Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. J Am Coll Cardiol. 2014;63(14):1405-13. PMCID:PMC4030008  PMID:24561146 
  63. Variability of M-mode versus two-dimensional echocardiography measurements in children with dilated cardiomyopathy. Pediatr Cardiol. 2014;35(4):658-67. doi:10.1007/s00246-013-0835-9  PMID:24265000 
  64. Tissue Doppler septal Tei index indicates severity of illness in pediatric patients with congestive heart failure. Pediatr Cardiol. 2014;35(3):411-8. PMCID:PMC3944049  PMID:24061276 
  65. Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function. J Heart Lung Transplant. 2014;33(2):170-7. PMCID:PMC3985609  PMID:24365764 
  66. Diagnosis and treatment of myocarditis in children in the current era. Circulation. 2014;129(1):115-28. PMID:24396015 
  67. Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry. Lancet. 2013;382(9908):1889-97. doi:10.1016/S0140-6736(13)61685-2  PMCID:PMC4007309  PMID:24011547 
  68. Heart transplantation in pediatric cardiomyopathies. Expert Rev Cardiovasc Ther. 2013;11(12):1677-90. PMID:24215197 
  69. Predictors of disease progression in pediatric dilated cardiomyopathy. Circ Heart Fail. 2013;6(6):1214-22. PMCID:PMC4111626  PMID:24132734 
  70. Post-transplant outcomes of children bridged to transplant with the Berlin Heart EXCOR Pediatric ventricular assist device. Circulation. 2013;128(11 Suppl 1):S24-31. doi:10.1161/CIRCULATIONAHA.112.000446  PMID:24030413 
  71. Measurement of donor-specific HLA antibodies following plasma exchange therapy predicts clinical outcome in pediatric heart and lung transplant recipients with antibody-mediated rejection. J Clin Apher. 2013;28(4):301-8. doi:10.1002/jca.21270  PMID:23426730 
  72. Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children. Circulation. 2013;127(16):1702-11. PMID:23538380 
  73. Predictors of disease progression in pediatric dilated cardiomyopathy. Circ Heart fail. 2013;6:1214. 
  74. Post-transplant outcomes of children bridged to transplant with the Berlin Heart Excor/Pediatric ventricular Device Circulation. 2013;128(S24):31. 
  75. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163-96. PMID:23245607 
  76. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197-223. PMID:23245608 
  77. Could contrast-enhanced cardiovascular MRI potentially be used to screen pediatric cardiac transplant patients for transplant coronary artery disease? Expert Rev Cardiovasc Ther. 2012;10(12):1459-61. doi:10.1586/erc.12.149  PMID:23253269 
  78. Noninvasive detection of transplant coronary artery disease with contrast-enhanced cardiac MRI in pediatric cardiac transplants. J Heart Lung Transplant. 2012;31(11):1234-5. doi:10.1016/j.healun.2012.06.001  PMID:22749830 
  79. Human polyomaviruses in children undergoing transplantation, United States, 2008-2010. Emerg Infect Dis. 2012;18(10):1676-9. doi:10.3201/eid1810.120359  PMCID:PMC3471627  PMID:23017293 
  80. Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the Pediatric Cardiomyopathy Registry. Circulation. 2012;126(10):1237-44. doi:10.1161/CIRCULATIONAHA.112.104638  PMID:22843787 
  81. Has late rejection decreased in pediatric heart transplantation in the current era? A multi-institutional study. J Heart Lung Transplant. 2012;31(9):980-6. doi:10.1016/j.healun.2012.05.016  PMID:22884385 
  82. Trends in the indications and survival in pediatric heart transplants: a 24-year single-center experience in 307 patients. Ann Thorac Surg. 2012;94(3):807-15; discussion 815-6. doi:10.1016/j.athoracsur.2012.02.052  PMID:22632881 
  83. Renal function and genetic polymorphisms in pediatric heart transplant recipients. J Heart Lung Transplant. 2012;31(9):1003-8. doi:10.1016/j.healun.2012.05.010  PMCID:PMC3428223  PMID:22789135 
  84. Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy. Circulation. 2012;126(9):1079-86. doi:10.1161/CIRCULATIONAHA.110.011999  PMID:22800850 
  85. Prospective trial of a pediatric ventricular assist device. N Engl J Med. 2012;367(6):532-41. doi:10.1056/NEJMoa1014164  PMID:22873533 
  86. The ventricular volume variability study of the Pediatric Heart Network: study design and impact of beat averaging and variable type on the reproducibility of echocardiographic measurements in children with chronic dilated cardiomyopathy. J Am Soc Echocardiogr. 2012;25(8):842-854.e6. doi:10.1016/j.echo.2012.05.004  PMID:22677278 
  87. Early survival after heart transplant in young infants is lowest after failed single-ventricle palliation: a multi-institutional study. J Heart Lung Transplant. 2012;31(5):509-16. doi:10.1016/j.healun.2011.12.013  PMID:22325692 
  88. Failed Fontan heart transplant candidates with preserved vs impaired ventricular ejection: 2 distinct patient populations. J Heart Lung Transplant. 2012;31(5):545-7. doi:10.1016/j.healun.2012.02.003  PMID:22381208 
  89. A risk-prediction model for in-hospital mortality after heart transplantation in US children. Am J Transplant. 2012;12(5):1240-8. doi:10.1111/j.1600-6143.2011.03932.x  PMID:22300640 
  90. Endomyocardial biopsy and selective coronary angiography are low-risk procedures in pediatric heart transplant recipients: results of a multicenter experience. J Heart Lung Transplant. 2012;31(4):398-409. doi:10.1016/j.healun.2011.11.019  PMCID:PMC3307902  PMID:22209354 
  91. Can adult heart failure regimens be applied to children: what works and what does not? Curr Opin Cardiol. 2012;27(2):98-107. PMID:22249216 
  92. Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry. J Am Coll Cardiol. 2012;59(6):607-15. doi:10.1016/j.jacc.2011.10.878  PMCID:PMC3280885  PMID:22300696 
  93. Extracardiac complications of the Fontan circuit. Pediatr Radiol. 2012;42(2):233-41. doi:10.1007/s00247-011-2225-x  PMID:21863291 
  94. ABO-incompatible heart transplantation: analysis of the Pediatric Heart Transplant Study (PHTS) database. J Heart Lung Transplant. 2012;31(2):173-9. doi:10.1016/j.healun.2011.11.013  PMID:22305379 
  95. Spontaneous echocardiographic contrast associated with portosystemic shunt due to persistent patent ductus venosus. Congenit Heart Dis. 2012;7(3):E18-21. doi:10.1111/j.1747-0803.2011.00587.x  PMID:22129147 
  96. Risk factors for late renal dysfunction after pediatric heart transplantation: a multi-institutional study. Pediatr Transplant. 2011;15(7):699-705. doi:10.1111/j.1399-3046.2011.01564.x  PMCID:PMC3201752  PMID:22004544 
  97. Outcomes after listing for primary transplantation for infants with unoperated-on non-hypoplastic left heart syndrome congenital heart disease: a multi-institutional study. J Heart Lung Transplant. 2011;30(9):1023-32. doi:10.1016/j.healun.2011.03.020  PMID:21550823 
  98. Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. Circulation. 2011;124(7):814-23. doi:10.1161/CIRCULATIONAHA.110.973826  PMCID:PMC3199969  PMID:21788591 
  99. Preventing thrombosis after the Fontan procedure not there yet. J Am Coll Cardiol. 2011;58(6):652-3. PMID:21798430 
  100. Recent clinical and translational research on pediatric myocarditis. Prog Pediatr Cardiol. 2011;32(1):15-18. PMCID:PMC3649092  PMID:23667302 
  101. The impact of heart failure severity at time of listing for cardiac transplantation on survival in pediatric cardiomyopathy. J Heart Lung Transplant. 2011;30(7):755-60. doi:10.1016/j.healun.2011.01.718  PMCID:PMC3110638  PMID:21419658 
  102. Gene polymorphisms impact the risk of rejection with hemodynamic compromise: a multicenter study. Transplantation. 2011;91(12):1326-32. doi:10.1097/TP.0b013e31821c1e10  PMID:21659963 
  103. Acute myocarditis in children. Expert Rev Cardiovasc Ther. 2011;9(6):771-83. PMID:21714608 
  104. Impact of pulmonary vascular resistances in heart transplantation for congenital heart disease. Curr Cardiol Rev. 2011;7(2):59-66. PMCID:PMC3197090  PMID:22548028 
  105. Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant. 2011;30(3):252-69. doi:10.1016/j.healun.2010.11.003  PMID:21300295 
  106. Infection and malignancy after pediatric heart transplantation: the role of induction therapy. J Heart Lung Transplant. 2011;30(3):299-308. doi:10.1016/j.healun.2010.09.005  PMID:21115369 
  107. Rejection with hemodynamic compromise in the current era of pediatric heart transplantation: a multi-institutional study. J Heart Lung Transplant. 2011;30(3):282-8. doi:10.1016/j.healun.2010.08.031  PMID:20974544 
  108. Outcomes of heart transplantation in young adults--more than a pediatric concern. J Heart Lung Transplant. 2011;30(2):139-40. PMID:21055969 
  109. Bridging children of all sizes to cardiac transplantation: the initial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device. J Heart Lung Transplant. 2011;30(1):1-8. doi:10.1016/j.healun.2010.08.033  PMID:21145473 
  110. Association of genetic polymorphisms and risk of late post-transplantation infection in pediatric heart recipients. J Heart Lung Transplant. 2010;29(12):1342-51. doi:10.1016/j.healun.2010.07.013  PMID:20869265 
  111. Outcomes of pediatric heart transplant recipients transitioned to adult care: an exploratory study. J Heart Lung Transplant. 2010;29(11):1309-10. doi:10.1016/j.healun.2010.06.005  PMID:20619681 
  112. Outcomes of heart transplantation using donor hearts from infants with sudden infant death syndrome. J Heart Lung Transplant. 2010;29(11):1226-30. doi:10.1016/j.healun.2010.06.004  PMID:20691612 
  113. Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry. Circ Heart Fail. 2010;3(6):689-97. doi:10.1161/CIRCHEARTFAILURE.109.902833  PMID:20833772 
  114. Dilated cardiomyopathy and heart failure in children. Heart Fail Clin. 2010;6(4):415-32, vii. PMID:20869643 
  115. The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart Fail Clin. 2010;6(4):401-13, vii. PMCID:PMC2946942  PMID:20869642 
  116. Cardiomyopathies: Treating pediatric DCM--great expectations unfulfilled. Nat Rev Cardiol. 2010;7(8):420-2. doi:10.1038/nrcardio.2010.87  PMID:20657608 
  117. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29(8):914-56. doi:10.1016/j.healun.2010.05.034  PMID:20643330 
  118. Decline in rejection in the first year after pediatric cardiac transplantation: a multi-institutional study. J Heart Lung Transplant. 2010;29(6):625-32. doi:10.1016/j.healun.2009.12.009  PMID:20207171 
  119. Current management of pediatric dilated cardiomyopathy. Curr Opin Cardiol. 2010;25(2):80-7. PMID:20019605 
  120. Tachyarrhythmias after pediatric heart transplantation. J Heart Lung Transplant. 2010;29(3):273-7. doi:10.1016/j.healun.2009.07.003  PMID:19783173 
  121. Distinct clinical and histopathological presentations of Danon cardiomyopathy in young women. J Am Coll Cardiol. 2010;55(4):408-10. doi:10.1016/j.jacc.2009.11.019  PMID:20117447